The Changing Clinical Spectrum of Hypophysitis

Sabrina Chiloiro, Ettore Domenico Capoluongo, Tommaso Tartaglione, Antonella Giampietro, Antonio Bianchi, Andrea Giustina, Alfredo Pontecorvi, Laura De Marinis

Risultato della ricerca: Contributo in rivistaArticolo in rivista

10 Citazioni (Scopus)


Hypophysitis is a rare and potentially life-threatening disease, characterized by an elevated risk of complications, such as occurrence of acute central hypoadrenalism, persistent hypopituitarism, or extension of the inflammatory process to the neighboring neurological structures. In recent years, a large number of patients have been described as being affected by hypophysitis, due to the increased administration of immuno-chemotherapies. At the present time, the heterogeneous nature of hypophysitis diagnostic criteria and of the treatment protocols makes the management of affected patients difficult. We review the current data and evidence on primary and secondary hypophysitis, in order to suggest a diagnostic and therapeutic protocol that should be focused on a multidisciplinary approach, for reaching a prompt diagnosis and an appropriate and safe treatment.
Lingua originaleEnglish
pagine (da-a)590-602
Numero di pagine13
RivistaTrends in Endocrinology and Metabolism
Stato di pubblicazionePubblicato - 2019


  • Hormone Replacement Therapy
  • Humans
  • Hypophysitis
  • Immunosuppressive Agents
  • Pituitary Gland
  • autoimmune
  • diabetes insipidus
  • hypopituitarism
  • immunotherapy
  • ipilimumab
  • pituitary


Entra nei temi di ricerca di 'The Changing Clinical Spectrum of Hypophysitis'. Insieme formano una fingerprint unica.

Cita questo